Sign Up
OverviewAPI
Alzheon, Inc. confirms U.S. Federal Circuit's backing of U.S. Patent Office's annulment of Risen (Suzhou) Pharmaceutical Technology Co., Ltd.’s patent on isotopically enriched forms of ALZ-801. Progress on APOLLOE4 Phase 3 trial for ALZ-801 in early Alzheimer’s patients continues.

Ask a question